World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
104
Citations
54176
World Ranking
6928
National Ranking
81

André Scheen publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where André Scheen sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 1,508 publications — 99th percentile

99% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

André Scheen D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where André Scheen sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 104 D-Index — 66th percentile

66% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

André Scheen is affiliated with the University of Liège in Belgium, with a primary focus on medicine. Their research spans over 241 publications in the medical field, with a specialization in endocrinology, diabetes, and metabolism. The subfields covered in their work also include molecular biology, pharmacology, surgery, and physiology.

The scientist's research topics address key aspects of diabetes and metabolism. These include:

  • Diabetes Treatment and Management
  • Metabolism, Diabetes, and Cancer
  • Pharmacology and Obesity Treatment
  • Diabetes Management and Research
  • Pancreatic function and diabetes
  • Diet and metabolism studies
  • Potassium and Related Disorders

André Scheen has contributed publications extensively in a number of venues frequently associated with diabetes and metabolic diseases. The main publication venues include:

  • Diabetes & Metabolism
  • Médecine des Maladies Métaboliques
  • Revue Médicale Suisse
  • Diabetes Epidemiology and Management
  • The Lancet Diabetes & Endocrinology

The researcher has collaborated with several frequent coauthors during their career. Notable colleagues include:

  • Pierre Delanaye
  • Michel Marre
  • Jean-François Gautier
  • Pierre Gourdy
  • Rudolf Prager

Recent publications by André Scheen document work on various aspects of diabetes treatment and complications. Selected papers include:

  • "Sodium-glucose cotransporter type 2 inhibitors for the treatment of type 2 diabetes mellitus," 2020, Nature Reviews Endocrinology
  • "Metformin and COVID-19: From cellular mechanisms to reduced mortality," 2020, Diabetes & Metabolism
  • "Prognostic factors in patients with diabetes hospitalized for COVID-19: Findings from the CORONADO study and other recent reports," 2020, Diabetes & Metabolism

Other notable papers associated with the field but authored by different researchers include studies on chronic kidney disease and cardiovascular outcomes, reflecting interconnected research interests within diabetic comorbidities.

Best Publications

  • Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial.

    John A. Dormandy;Bernard Charbonnel;David J A Eckland;Erland Erdmann

  • ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD)

    Lars Ryden;Peter J. Grant;Stefan D. Anker;Christian Berne

  • Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes.

    Nathalie Esser;Sylvie Legrand-Poels;Jacques Piette;André J. Scheen

  • Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

    Luc F Van Gaal;Aila M Rissanen;André J Scheen;Olivier Ziegler

  • Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

    Adrian F Hernandez;Jennifer B Green;Salim Janmohamed;Ralph B D'Agostino

  • Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study

    André J Scheen;Nick Finer;Priscilla Hollander;Michael D Jensen

  • Effect of valsartan on the incidence of diabetes and cardiovascular events.

    John McMurray;R Holman;Steven Haffner;M Bethel

  • Clinical pharmacokinetics of metformin.

    André J. Scheen

  • RECOMMANDATIONS 2012 EN DIABÉTOLOGIE: Prise en charge de l'hyperglycémie dans le diabète de type 2: une approche centrée sur le patient

    André Scheen;Chantal Mathieu

  • Roles of circadian rhythmicity and sleep in human glucose regulation

    E. Van Cauter;K. S. Polonsky;André Scheen

  • 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial

    Carel W le Roux;Carel W le Roux;Arne Astrup;Ken Fujioka;Frank Greenway

  • Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty.

    Françoise Luyckx;Claude Desaive;Albert Thiry;W. Dewe

  • Effect of nateglinide on the incidence of diabetes and cardiovascular events

    Rury R. Holman;Steven M. Haffner;Steven M. Haffner;John J. McMurray;M. Angelyn Bethel;M. Angelyn Bethel

  • Pharmacodynamics, efficacy and safety of sodium-glucose co-transporter type 2 (SGLT2) inhibitors for the treatment of type 2 diabetes mellitus.

    André J. Scheen

  • Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication

    Marc A. De Hert;Ruud van Winkel;Dominique Van Eyck;Linda Hanssens

  • Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss.

    Françoise Luyckx;Pierre Lefebvre;André Scheen

  • Prevention of type 2 diabetes mellitus through inhibition of the renin-angiotensin system

    André J Scheen

  • Magnesium and glucose homeostasis

    G. Paolisso;André Scheen;F. D'Onofrio;Pierre Lefebvre

  • Renin-angiotensin system inhibition prevents type 2 diabetes mellitus - part 1: a meta-analysis of randomised clinical trials

    André Scheen

  • Pharmacokinetics of dipeptidylpeptidase-4 inhibitors.

    André Scheen

Frequent Co-Authors

Marc De Hert
Marc De Hert KU Leuven
Luc Van Gaal
Luc Van Gaal University of Antwerp
Patrizio Lancellotti
Patrizio Lancellotti University of Liège
Giuseppe Paolisso
Giuseppe Paolisso University of Campania "Luigi Vanvitelli"
Jean-Pierre Després
Jean-Pierre Després Université Laval
Jacques Piette
Jacques Piette University of Liège
Jean-Yves Reginster
Jean-Yves Reginster University of Liège
Jaakko Tuomilehto
Jaakko Tuomilehto University of Helsinki
Ole Schmitz
Ole Schmitz Aarhus University Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring career options related to medicine doesn't have to be limited to traditional MD programs. Today, there are several flexible online degrees that let you advance your medical career or enter the healthcare field from different pathways.

For nurses seeking the highest level of practice, the cheapest BSN to DNP programs offer an affordable and convenient route to a Doctor of Nursing Practice degree. Likewise, pharmacy professionals can consider the best online pharmacy school programs to gain advanced qualifications with flexible study options.

If you’re interested in the growing field of digital health records and analytics, accredited healthcare informatics degree programs can help you enter or advance in health information management roles. For those interested in medical administration, you can quickly start a career from home with billing and coding classes online.

These online pathways can be stepping stones to lucrative healthcare careers—some even without the need for previous clinical experience or medical school. They allow you to specialize, upskill, or transition into healthcare with more flexibility than ever before.

Best Scientists Citing André Scheen

Trending Scientists

Recently Published Articles